Precision medicine in obstructive sleep apnoea
MA Martinez-Garcia, F Campos-Rodriguez… - The Lancet …, 2019 - thelancet.com
Obstructive sleep apnoea (OSA) is a heterogeneous and complex disease; however,
diagnosis and management still rely on a simple set of tools and few therapeutic options …
diagnosis and management still rely on a simple set of tools and few therapeutic options …
The renin-angiotensin system in the central nervous system and its role in blood pressure regulation
P Nakagawa, J Gomez, JL Grobe… - Current hypertension …, 2020 - Springer
Abstract Purpose of the Review The main goal of this article is to discuss how the
development of state-of-the-art technology has made it possible to address fundamental …
development of state-of-the-art technology has made it possible to address fundamental …
Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation
O Azzam, SH Nejad, R Carnagarin… - British Journal of …, 2024 - Wiley Online Library
Resistant hypertension is associated with an exceedingly high cardiovascular risk and there
remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by …
remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by …
Targeting brain aminopeptidase A: a new strategy for the treatment of hypertension and heart failure
Y Marc, SE Boitard, F Balavoine, M Azizi… - Canadian Journal of …, 2020 - Elsevier
The pathophysiology of heart failure (HF) and hypertension are thought to involve brain
renin-angiotensin system (RAS) hyperactivity. Angiotensin III, a key effector peptide in the …
renin-angiotensin system (RAS) hyperactivity. Angiotensin III, a key effector peptide in the …
Modulation of sympathetic overactivity to treat resistant hypertension
R Voora, AL Hinderliter - Current Hypertension Reports, 2018 - Springer
Abstract Purpose of Review To review the role and evidence for sympathetic overactivity in
resistant hypertension and review the therapies that have been studied to modulate the …
resistant hypertension and review the therapies that have been studied to modulate the …
Genetics of resistant hypertension: a novel pharmacogenomics phenotype
N El Rouby, RM Cooper-DeHoff - Current hypertension reports, 2015 - Springer
Resistant hypertension (RHTN), defined as an uncontrolled blood pressure despite the use
of multiple antihypertensive medications, is an increasing clinical problem associated with …
of multiple antihypertensive medications, is an increasing clinical problem associated with …
Blood pressure control and cardiovascular/renal outcomes
FK Dojki, GL Bakris - Endocrinology and Metabolism Clinics, 2018 - endo.theclinics.com
Diabetes mellitus (DM) is a growing epidemic. By 2030, it is projected that there will be at
least 400 million individuals with type 2 DM worldwide, with many of those affected being …
least 400 million individuals with type 2 DM worldwide, with many of those affected being …
Использование современных медицинских технологий для диагностики и лечения больных артериальной гипертонией
ВФ Мордовин, СЕ Пекарский, ГВ Семке… - Сибирский журнал …, 2015 - cyberleninka.ru
Работа выполнена с использованием комплекса современных клинико-
инструментальных методов исследования. Представлен разработанный авторами …
инструментальных методов исследования. Представлен разработанный авторами …
New molecules for treating resistant hypertension: a clinical perspective
O Azzam, MG Kiuchi, JK Ho, VB Matthews… - Current Hypertension …, 2019 - Springer
Abstract Purpose of Review To review the findings of trials evaluating pharmacological
treatment approaches for hypertension in general, and resistant hypertension (RH) in …
treatment approaches for hypertension in general, and resistant hypertension (RH) in …
[PDF][PDF] Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.
A Şahinarslan, E Gazi, M Aktoz… - Anatolian Journal of …, 2020 - jag.journalagent.com
Background Hypertension is one of the major cardiovascular risk factors, closely related to
the major cardiovascular, neurological, and renal adverse events (1, 2). Resistant …
the major cardiovascular, neurological, and renal adverse events (1, 2). Resistant …